Monthly Archives: May 2014

Forbes: Sure, We’ll (Eventually) Beat Cancer. But Can We Afford To?

Biopharmaceuticals and Accountable Care Organizations: Balancing Cost and Quality

On May 19, Paul Howard highlighted the promise of immunotherapy for the treatment and possible eventual cure of cancer but emphasized that it is critical to focus on the long-term perspective. Key points raised in the article: ‘Reducing incentives for innovation (and drug development returns are roughly comparable to those in the software industry) and you would encourage investors to park more of their capital in more lucrative investments (think: Snapchat), and less into research for Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Media Overview of the 2014 World Congress on Industrial Biotechnology

World Congress

The BIO World Congress on Industrial Biotechnology is the world’s largest industrial biotechnology event for business leaders, investors, and policy makers in biofuels, biobased products, and renewable chemicals. This year’s World Congress was held May 12-15, 2014 in Philadelphia at the Pennsylvania Convention Center. Media in attendance included: Melody Bomgardner, Chemical & Engineering News Geoffrey Carr, The Economist  Rebecca Coons, Chemical Week Philippa Davies, Tecnon OrbiChem Doris De-Guzman, Tecnon OrbiChem Dick Flanagan, World-Generation Neil Eisberg, Chemistry & Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , ,

THBI to Honor Texas House of Representatives Speaker Joe Straus

THBI

It’s no secret that Texas’ economy is booming and has been for some time. An important part of that growth has come from knowledge sectors, such as biotechnology. The biotech industry in Texas has expanded by about 20% through the last decade. This type of growth doesn’t just happen on its own. It requires careful planning and coordination between academia, industry and willing investors. There is one further element, whose importance cannot be understated. Responsible Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO Testifies at 21st Century Cures Hearing on PCAST

TheHill

Today, BIO’s Executive Vice President of Health Sara Radcliffe presented testimony to the U.S. House of Representatives Energy and Commerce Subcommittee on Health Hearing. The Hearing focused on the President’s Council of Advisors on Science and Technology (PCAST) Report on Drug Innovation and key issues related to the 21st Century Cures initiative to examine what steps the Committee can take to accelerate the pace of cures in America. Below is a summary: The Challenge of Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

BIO Innovation Zone Company Snapshots: PhylloTech, LLC

InnovationZone_Logo_SBIR Companies_VERT_lockup

Next month in San Diego at the BIO International Convention, BIO will be partnering with the National Science foundation (NSF) and the National Institutes of Health (NIH)to host the first-ever BIO Innovation Zone. The Zone will feature Small Business Innovation Research (SBIR) funded early-stage biotech companies. The SBIR/STTR program provides U.S. federal funding to small businesses engaged in research with the potential for commercialization. Companies are rigorously vetted through the NIH and NSF SBIR review process Read More >

Events, Food And Agriculture  |  Leave a comment  |  Email This Post
Tags: , , , , ,